REGISTERED NUMBER: 05833629 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

FOR

NATIONWIDE MEDICAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Professor R J Schilling

Mrs C E Schilling

REGISTERED OFFICE:

c/o Professor Schilling

5 Frank Dixon Close

London

SE21 7BD

REGISTERED NUMBER:

05833629 (England and Wales)

ACCOUNTANTS:

Sandison Easson & Co

Rex Buildings

Alderley Road

Wilmslow

Cheshire

SK9 1HY

FIXED ASSETS

Tangible assets

4

-

-

Investments

5

874,500

505,295

874,500

505,295

CURRENT ASSETS

Debtors

6

200,253

255,429

Cash at bank

1,261,012

853,545

1,461,265

1,108,974

CREDITORS

Amounts falling due within one year

7

142,054

133,979

NET CURRENT ASSETS

1,319,211

974,995

TOTAL ASSETS LESS CURRENT LIABILITIES

2,193,711

1,480,290

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

2,193,611

1,480,190

2,193,711

1,480,290

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 September 2025 and were signed on its behalf by:

Professor R J Schilling - Director

1.	STATUTORY INFORMATION

Nationwide Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

RELATED PARTY EXEMPTION

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

TURNOVER

The turnover shown in the profit and loss account represents amount earned during the year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Plant and machinery - 25% Straight line

Computer equipment - 25% Straight line

All fixed assets are initially recorded at cost.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

Computer

machinery

equipment

Totals

£

£

£

COST

At 1 July 2024

and 30 June 2025

25,945

2,144

28,089

DEPRECIATION

At 1 July 2024

and 30 June 2025

25,945

2,144

28,089

NET BOOK VALUE

At 30 June 2025

-

-

-

At 30 June 2024

-

-

-

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 July 2024

505,295

Additions

369,205

At 30 June 2025

874,500

NET BOOK VALUE

At 30 June 2025

874,500

At 30 June 2024

505,295

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

27,214

23,785

Other debtors

45,580

45,580

Other Loans

127,459

186,064

200,253

255,429

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

8

-

Tax

126,480

121,810

PAYE and national insurance

1,581

1,749

Credit Card

8,317

5,161

Directors' current accounts

133

72

Accrued expenses

5,535

5,187

142,054

133,979